OpenAI CEO Sam Altman is stepping down as board chair of the Helion — the fusion startup he backs — amid reported talks between the two companies. If the figures in Axios’ report prove to be accurate, ...
BAY HARBOR ISLAND, Fla. (AP) — BAY HARBOR ISLAND, Fla. (AP) — Fortress Biotech Inc. (FBIO) on Tuesday reported a loss of $3.9 million in its fourth quarter. The Bay Harbor Island, Florida-based ...
SAN ANTONIO — More than $26 million in grant funding is being distributed to support infrastructure projects in military communities across Texas, with a portion earmarked for San Antonio. Greg Abbott ...
CINCINNATI (WKRC) - Sam’s Club shoppers will soon pay more to keep their memberships, as the Walmart-owned retailer moves to raise annual fees starting May 1, 2026. In a notice to members, Sam’s Club ...
Takeda has posted phase 3 data on an autoimmune asset it acquired for $4 billion, laying down a marker ahead of a fight for market share with companies including Bristol Myers Squibb and Johnson & ...
US dollar-denominated funds could face more hurdles when investing in Chinese tech and biotech companies as Beijing adopts a stricter approach to companies seeking listings via offshore incorporated ...
Large language models trained on vast datasets could speed genomics research, streamline clinical documentation, improve real-time diagnostics, support clinical decision-making, accelerate drug ...
KANSAS CITY, Mo. –The man northern Missourians are sending to Congress will no longer be Sam Graves; the longtime Republican has announced he will not seek reelection this year. The Tarkio, Mo. native ...
Flowers Foods, Inc. engages in the production and marketing of packaged bakery foods. It offers breads, buns, rolls, snack items, bagels, English muffins, and tortillas and are sold under a variety of ...
Seattle Seahawks quarterback Sam Darnold floats a perfect 16-yard pass into the hands of tight end AJ Barner for the first touchdown of "Thursday Night Football". Seahawks linebacker Ernest Jones IV ...
March 23 (Reuters) - Gilead Sciences is nearing an acquisition of Ouro Medicines, a biotech focused on immune disorder treatments, for up to $2 billion, the Financial Times reported on Monday. Under ...